Guidelines for the thyroid diseases diagnosis and management in pregnancy and women with fertility disorders

Literatura k doporučení ČES ČLS JEP 4. 10. 2012

1. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Clinical Practice Guideline. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92(8 Suppl): S1–47.

2. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004; 251(9): 1133–1137.

3. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen R. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. New Engl J Med 2004; 351: 349–353.

4. Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De Escobar G, Berbel P. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004; 145: 4037–4044.

5. Barbero P, Valdez R, Rodriguez H, Barbero P, Valdez R, Rodríguez H, Tiscornia C, Mansilla E, Allons A, Coll S, Liascovich Ret al: Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet 2008; 146A: 2390–2395.

6. Bath SC, Rayman MP. Antenatal thyroid screening and childhood cognitive function New Engl J Med 2012; 366(17): 1640–1641.

7. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TGM, Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal and neonatal death. Eur J Endocrinol 2009; 160: 985–991.

8. Braverman LE, Utiger RD. Introduction to thyrotoxicosis. In: Braverman LE, Utiger RD (eds). Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. 9th ed. Lippincott, Williams and Wilkins: Philadelphia 2005: 453–455.

9. Brent GA. The debate over toroid function screening in pregnancy. New Engl J Med 2012; 366(6): 562–563.

10. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Nationa Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197(6): 585. e1–7; discussion 683–684, e1–7.

11. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107(2 Pt 1): 337–341.

12. Cassina M, Dona M, Di, Gianantonio E, Clementi M. Pharmacologic treatment of hyperthyroidism during pregnancy Birth Defects Res a Clin Mol Teratol 2012; 94(8): 612–619.

13. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P. SAFE-Med Study Group. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010; 95: E337–41.

14. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999; 83: 43–46.

15. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nobles and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19: 1167–1214.

16. Costante G, Meringolo D, Durante C Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450–455.

17. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society practice guidelines. J Clin Endocrinol Metab 2012; 97: 2543–2565.

18. Delange F. Optimal iodine nutrition during pregnancy, lactation and the neonatal period. J Clin Endocr Metab 2004; 2: 1–12.

19. Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 2008; 158(6): 841–851.

20. Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 2012; 97: 1536–1546.

21. Galofre JC, Haber RS, Mitchell AA, Pessah R, Davies TF. Increased postpartum thyroxine replacement in Hashimoto’s thyroiditis. Thyroid 2010; 20: 901–908.

22. Garsi JP, Schlumberger M, Rubino C, Ricard M, Labbé M, Ceccarelli C, Schvartz C, Henri-Amar M, Bardet S, de Vathaire FC. Therapeutic administration of 1311 for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med 2008; 49: 845–852.

23. Ghassabian A, Bongers-Schokking JJ, de Rijke YB. Maternal thyroid autoimmunity during pregnancy and the the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid 2012; 22(2): 178–186.

24. Gibelli B, Zamperini P, Tradati N. Pregnancy and thyroid cancer. Recent Results Cancer Res 2008; 178: 123–126.

25. Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, Kinthaert J, Robijn C, Grun JP, de Nayer P. Pregnancy in patiens with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991; 73: 421–427.

26. Glinoer D Riahi M, Grun JP, Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994; 79: 197–204.

27. Haas J. High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 2000; 6(Suppl 2): 18–20: discussion S33.

28. Hartl DM, Travagli JP. The Updated American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated thyroid cancer. A surgical perspective Thyroid 2009; 19(11): 1149–1151.

29. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102–132.

30. Hirsch D, Levy S, Tsvetov G, Weinstein R, Lifshitz A, Singer J, Shraga-Slutzky I, Grozinski-Glasberg S, Shimon I, Benbassat C. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid 2010; 20: 1179–1185.

31. Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, Cepkova J, Mc Grath C, Maly J. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010; 163: 645–650.

32. Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011; 96(9): E1452–33.

33. Jiskra J, Bartáková J, Holinka S, Límanová Z, Springer D, Fait T, Antošová M, Telicka Z, Potluková E. Low concordance between positive antibodies to thyroperoxidase and thyroid ultrasound autoimmune pattern in pregnant women. Endocr J 2011; 58(10): 849–859.

34. Jiskra J, Bartáková J, Holinka Š, Límanová Z, Springer D, Antošová M, Telička Z, Potluková E. Low prevalence of clinically high-risk women and pathological thyroid ultrasound among pregnant women positive in universal screening for tyroid disorders. Exp Clin Endocrinol Diabetes 2011; 119(9): 530–535.

35. Krassas GE, Poppe K, Glinoer G. Thyroid function and human reproductive health Endocr Rev 2010; 31(5): 702–755.

36. Kung AW, Chau MT, Lao TT, Tam SC, Low LC Chau MT, Lao TT. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002; 87: 1010–1014.

37. Lazarus JH. Thyroid screening in pregnancy. In: Lazarus JH, Pirags V, Butz S. The thyroid and reproduction. Merck European Thyroid Symposium. Georg Tieme Verlag: Stuttgart 2008: 105–113.

38. Lazarus JH, Betswick JP, Channon S, Paradice R, Maina A, Ries R, Chiusano E, John R, Guaraldo V, George LM, Perona M, Dall’Amico D, Parkes AB, Joomun M, Wald NJ. Antenatal thyroid screening and childhood cognitive function. New Engl J Med 2012; 366: 493–501.

39. Lee M, O’Brien P. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 1308–1311.

40. Límanová Z, Zamrazil V. Má být zaveden screening funkčních tyreoidálních onemocnění u dospělých v České republice? DMEV 2004; 7(3): 124–130.

41. Límanová Z, Springer D. Současné zkušenosti s vyšetřováním tyreopatií v graviditě – výsledky pilotního projektu. Čas Lék Čes 2011; 150: 389–393.

42. Marley F, Oertel YC. Fine needle aspiration of thyroid lesions in 57 pregnant and postpartum women. Diagn Cytopathol 1997; 16: 122–125.

43. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptorantibodies. Thyroid 1992; 2:155–159.

44. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004; 18: 225–248.

45. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 2005; 20: 1529–3346.

46. Negro R, Formoso G, Mangieri T , Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587–2591.

47. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95: 1699–1707.

48. Negro R, Soldin OP, Obregon MJ, Stagnaro-Green A. Hypothyroxinemia and pregnancy. Endocr Pract 2011(a); 17: 422–429.

49. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 2011(b); 96: E920-E924.

50. Negro R, Stagnaro-Green A. Thyroid antibodies, preterm birth, and miscarriage. The association is clear, but the effects of levothyroxine treatment are uncertain. Brit Med J 2011(c); 342: d2260.

51. Niebyl JR. Clinical practice. Nausea an pregnancy. N Engl J Med 2010; 363: 1544–1550.

52. Nüssgens Z, Roggenkämper P, Schweikert HU. Development of endocrine orbitopathy in pregnancy. Klin Monbl Augenheilkd 1993; 202(2): 130–133.

53. Osorio J. Thyroid screening in pregnancy – no effect on child cognition? Nature Reviews Endocrinology 2012; 8: 193.

54. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European Thyroid Cancer Taskforce – European Thyroid Cancer Taskforce 2006. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787–803.

55. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European Thyroid Cancer Taskforce A systematic review examining the effect of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf ) 2008; 69: 479–490.

56. Patil-Sisodia K, Mestman JH. Graves hyperthyroidism 2010. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract 2010; 16: 118–129.

57. Pop V, Brouwers EP, Vader HL, Vulsma T, Van Baar AL, De Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003; 59: 282–288.

58. Potlukova E, Potluka O, Jiskra J, Limanova Z, Telicka Z, Bartakova J, Springer D. Is Age a Risk Factor for Hypothyroidism in Pregnancy? An Analysis of 5223 Pregnant Women. J Clin Endocrinol Metab 2012; 97(6):1945–1952.

59. Rosen IB, Walfish PG. Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg 1986; 121: 1287–1290.

60. Rubin PC. Current concepts: beta-blockers in pregnancy.N Engl J Med 1981; 305: 1323–1326.

61. Russo MW, Galanko JA, Shrestha R, Fried MW. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107 (2 Pt 1): 337–341.

62. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128–1135.

63. Springer D, Horáček J, Hauerová D, Límanová Z. Poruchy štítné žlázy v těhotenství: souhrn výsledků nezávislých studií. Čes Gynek 2007; 72(6): 375–381.

64. Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 2009; 160: 791–797.

65. Stafford IP, Dildy GA 3rd, Miller JM Jr. Severe Graves‘ ophthalmopathy in pregnancy. Obstet Gynecol 2005; 105(5 Pt 2): 1221–1223.

66. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011(a); 21: 1–45.

67. Stagnaro-Green A, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Negro R. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroidits in southern Italy. J Clin Endocrinol Metab 2011(b); 96: 652–657.

68. Struve CV, Haupt S, Ohlen S. Influence in frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 1993; 3(1): 7–9.

69. Tan GH, Gharib H, Goellner JR, van Heerden JA, Bahn RS. Management of thyroid nodules in pregnancy. Arch Intern Med 1996; 156: 122–125.

70. Tan JY, Loh KC, Yeo GS, Chee YC. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002; 109: 683–688.

71. Telička Z, Jiskra J, Springer D. Simple Method of Economical Analysis of Diagnosis Procedure (Used in Screening of Thyroid Gland Diseases in Pregnant Women) during the first trimester of pregnancy. European Journal for Biomedical Informatics 2010. Dostupné z WWW: <http://www.ejbi.org/en/ejbi/article/59-cs-jednoducha-ekonomicka-analyza-diagnostiky-nemoci-stitne-zlazy-pri-screeningu-tehotnych-zen.html>.

72. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. Brit Med J 2011; 342: d2616. Dostupné z DOI: <http://doi: 10.1136/bmj.d2616>.

73. Thung SF, Funai EF, Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol. 2009; 200(3): 267. Dostupné z DOI: <http://doi: 10.1016/j.ajog.2008.10.035>.

74. Vaidya B, Anthony S, Bilous M et al. Detection of toroid dysfunction in early pregnancy: Universal screening or targeted high risk case finding? J Clin Endocrinol Metab 2007; 92: 203–207.

75. Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, Zhou J, Mao J, Yu X, Li J, Chen Y, Xue H, Fan C, Wang H, Zhang H, Li C, Zhou W, Gao B, Shang T, Zhou J, Ding B, Ma Y, Wu Y, Xu H, Liu W. The prevalence of thyroid disorders during early pregnancy in China: the benefity of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011; 164(2): 263–268.

76. Wiliams GR. Neurodevelopment and neurophysiological actions of thyroid hormone. J Neuroendocrinol 2008; 20(6): 784–794.

77. Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY trial). J Clin Endocrinol Metab 2010; 95: 3234–3241.

78. Yoshira A, Noh J, Yamaguchi T Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K. Treatment of Grave’s disease with antithyroid drugs in the first trimestr of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012; 97(7): 2396–2403.

79. Zamrazil V, Bilek R, Cerovska J, Delange F. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid 2004; 14: 49–56.

80. Zamrazil V, Bílek R, Čeřovská J, Dvořáková M, Němeček J. Jodový deficit ve světě i v České republice – současný stav a perspektivy. Vnitř Lék 2010; 56(12): 1310–1315.

81. Zimmermann M, Delange F. Iodine supplementation of pregnant women in Europe. A review and recomendation. Eur J Clin Nutr 2004; 58: 979–984.